Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 184.6B | 187.7B | 177.4B | 175.1B |
Cost of revenue | 85.1B | 83.3B | 79.1B | 81.1B |
Gross profit | 142.1B | 146.0B | 137.8B | 134.6B |
Operating expense | ||||
Research & development | 27.4B | 26.7B | 25.5B | 25.3B |
Selling general and admin | 77.5B | 79.6B | 75.8B | 73.9B |
Other operating expenses | — | — | — | — |
Operating income | 37.1B | 39.8B | 36.6B | 35.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -75.1M | -2.4B | -3.8B | -845.1M |
Pretax income | 37.1B | 37.3B | 32.8B | 34.5B |
Tax provision | 8.1B | 5.3B | 4.1B | 7.7B |
Net income | 28.9B | 32.1B | 28.7B | 26.8B |
Basic EPS | 1.6 | — | 1.6 | 1.5 |
Diluted EPS | 1.6 | — | 1.6 | 1.5 |
Basic average shares | 18.0B | — | 18.0B | 18.1B |
Diluted average shares | 18.2B | — | 18.1B | 18.3B |
EBITDA | 54.8B | 60.0B | 57.0B | 54.9B |
Net income from continuing op. | 28.9B | 32.1B | 28.7B | 26.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |